Question 1

What is the catalog number for HDHODH-IN-13?

Accepted Answer

The catalog number for HDHODH-IN-13 is orb1942543.

Question 2

What sizes are available for HDHODH-IN-13?

Accepted Answer

HDHODH-IN-13 is available in the following size(s): 5 mg, 50 mg.

Question 3

How many pack sizes does HDHODH-IN-13 come in?

Accepted Answer

HDHODH-IN-13 is available in 2 different pack sizes.

Question 4

Is HDHODH-IN-13 in stock?

Accepted Answer

HDHODH-IN-13 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is HDHODH-IN-13 used for?

Accepted Answer

HDHODH-IN-13 (compound w2) is a potent human dihydroorotate dehydrogenase inhibitor with an IC50 of 173.4 nM. It is applied in inflammatory bowel disease (IBD) research, demonstrating activity in vitro enzyme assays and in vivo animal models, supporting immunology and therapeutic discovery studies.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 8

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

HDHODH-IN-13

Product Specifications

CAS Number

Field of Research

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Sox30 Mouse Gene Knockout Kit (CRISPR)

Frozen Tissue Sections, Colon: right

Aminoacylase 1 (ACY1) Rabbit Polyclonal Antibody

Bicyclo[4.1.0]heptane-7-carboxylic Acid

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF640R conjugate, 0.1mg/mL

HSP75 Polyclonal Antibody